Literature DB >> 25398738

The science upon which to base dietary sodium policy.

Michael H Alderman1.   

Abstract

Few nutrient intake recommendations become subjects of heated scientific debate, but sodium is 1 of them. In the absence of sufficient clinical trials focused on sodium intake and health outcomes, studies that used the surrogate marker of blood pressure have been used to support extreme sodium reduction. Under tightly controlled conditions, maximum achievable sodium reduction leads to a 1-6 mm Hg reduction in systolic blood pressure, which presumably leads to reduced cardiovascular disease morbidity and mortality. However, in observational cohort studies that used not blood pressure but actual health conditions as outcomes, the presumed relation between sodium intakes <2500 mg/d was not observed. Thus, the blood pressure effect of sodium restriction can no longer be accepted as a surrogate for health outcomes associated with sodium intake. Evidence that reducing sodium intakes to <2500 mg/d will improve health is needed to justify continuing efforts to modify diet.
© 2014 American Society for Nutrition.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25398738      PMCID: PMC4224212          DOI: 10.3945/an.114.006593

Source DB:  PubMed          Journal:  Adv Nutr        ISSN: 2161-8313            Impact factor:   8.701


  22 in total

1.  Reducing the public health burden from elevated blood pressure levels in the United States by lowering intake of dietary sodium.

Authors:  Stephen Havas; Edward J Roccella; Claude Lenfant
Journal:  Am J Public Health       Date:  2004-01       Impact factor: 9.308

Review 2.  Compared with usual sodium intake, low- and excessive-sodium diets are associated with increased mortality: a meta-analysis.

Authors:  Niels Graudal; Gesche Jürgens; Bo Baslund; Michael H Alderman
Journal:  Am J Hypertens       Date:  2014-03-20       Impact factor: 2.689

3.  A call for higher standards of evidence for dietary guidelines.

Authors:  Paul R Marantz; Elizabeth D Bird; Michael H Alderman
Journal:  Am J Prev Med       Date:  2008-03       Impact factor: 5.043

4.  Presidential Address: 21st Scientific Meeting of the International Society of Hypertension: dietary sodium and cardiovascular disease: the 'J'-shaped relation.

Authors:  Michael H Alderman
Journal:  J Hypertens       Date:  2007-05       Impact factor: 4.844

5.  Effects of sodium restriction on blood pressure, renin, aldosterone, catecholamines, cholesterols, and triglyceride: a meta-analysis.

Authors:  N A Graudal; A M Galløe; P Garred
Journal:  JAMA       Date:  1998-05-06       Impact factor: 56.272

6.  Compelling evidence for public health action to reduce salt intake.

Authors:  Lawrence J Appel; Cheryl A M Anderson
Journal:  N Engl J Med       Date:  2010-01-20       Impact factor: 91.245

7.  Dietary and other risk factors for stroke in Hawaiian Japanese men.

Authors:  A Kagan; J S Popper; G G Rhoads; K Yano
Journal:  Stroke       Date:  1985 May-Jun       Impact factor: 7.914

8.  Low urinary sodium is associated with greater risk of myocardial infarction among treated hypertensive men.

Authors:  M H Alderman; S Madhavan; H Cohen; J E Sealey; J H Laragh
Journal:  Hypertension       Date:  1995-06       Impact factor: 10.190

9.  Incidence of stroke in Taiwan.

Authors:  H H Hu; W Y Sheng; F L Chu; C F Lan; B N Chiang
Journal:  Stroke       Date:  1992-09       Impact factor: 7.914

Review 10.  Salt intake, stroke, and cardiovascular disease: meta-analysis of prospective studies.

Authors:  Pasquale Strazzullo; Lanfranco D'Elia; Ngianga-Bakwin Kandala; Francesco P Cappuccio
Journal:  BMJ       Date:  2009-11-24
View more
  2 in total

1.  Is dietary sodium policy actually based on science?

Authors:  Simon N Thornton
Journal:  Adv Nutr       Date:  2015-05-15       Impact factor: 8.701

2.  Potassium urinary excretion and dietary intake: a cross-sectional analysis in 8-10 year-old children.

Authors:  Ana Catarina Oliveira; Patrícia Padrão; André Moreira; Mariana Pinto; Mafalda Neto; Tânia Santos; Joana Madureira; Eduardo de Oliveira Fernandes; Pedro Graça; João Breda; Pedro Moreira
Journal:  BMC Pediatr       Date:  2015-05-17       Impact factor: 2.125

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.